But survival improved with intensity of treatment
SAN FRANCISCO — Older patients with esophageal or unresected gastric cancer benefited from treatment but often received no cancer-specific therapy, analyses of a large national database suggested.
An analysis of 21,593 patients ages ≥70 with locally advanced esophageal cancer showed that 13% received no treatment at all, and an additional 24% received palliative care. Only 10% of the patients received optimal trimodal therapy (surgery, chemotherapy, and radiation therapy).
Median overall survival (OS) improved with intensity of treatment, from 3.6 months with no treatment to 26.8 months with trimodal therapy, reported Gregory Vlacich, MD, PhD, of Washington University in St. Louis, and colleagues at the Gastrointestinal Cancers Symposium.
Read Full Article Here >>